Aligos Therapeutics (ALGS) Revenue (2019 - 2026)
Aligos Therapeutics (ALGS) posted Revenue of $2.83 million for Q3 2026, up 281.9% from $741,000 a year earlier.
Aligos Therapeutics (ALGS) Revenue (2019 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Revenue at Aligos Therapeutics was $5.83 million, up 122.2% year-over-year; for FY2025, it was $2.19 million, down 39.5% from FY2024.
- Annual Revenue has declined for three consecutive years, though with a five-year compound annual growth rate of 9.8% (FY2020 to FY2025).
- In prior years, Aligos Therapeutics' Revenue was $3.61 million in FY2024 (-61.3%), $9.34 million in FY2023 (-32.9%), $13.91 million in FY2022 (+219.0%) and $4.36 million in FY2021 (+218.6%).
- Quarterly Revenue has run from a low of $169,000 in Q4 2025 to a high of $4.29 million in Q2 2023 over five years.
- On a year-over-year basis, Revenue increased in two of the last seven quarters, with growth averaging 120.7%.
- The strongest year-over-year quarter for Revenue in the past five years was Q4 2022, with growth of 863.8%; the weakest was Q2 2024, with a decline of 75.3%.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 24.40 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 17.40 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 18.09 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 15.07 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 10.37 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 8.30 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 16.58 Bn |
| 10 | Aligos Therapeutics | 21.97 Mn | -314.86 Mn | - | 2.83 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.83 Mn |
| Mar 31, 2026 | 2.83 Mn |
| Dec 31, 2025 | 169,000.00 |
| Sep 30, 2025 | 741,000.00 |
| Jun 30, 2025 | 965,000.00 |
| Mar 31, 2025 | 311,000.00 |
| Dec 31, 2024 | 606,000.00 |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 1.06 Mn |
| Mar 31, 2024 | 694,000.00 |
| Dec 31, 2023 | 2.01 Mn |
| Sep 30, 2023 | 2.15 Mn |
| Jun 30, 2023 | 4.29 Mn |
| Mar 31, 2023 | 2.58 Mn |
| Dec 31, 2022 | 3.54 Mn |
| Sep 30, 2022 | 4.11 Mn |
| Jun 30, 2022 | 3.69 Mn |
| Mar 31, 2022 | 2.57 Mn |
| Dec 31, 2021 | 367,000.00 |
| Sep 30, 2021 | 1.54 Mn |
Aligos Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ALGS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();